Jackie Tran joined Kura in February 2015 and serves as our Vice President. Prior to her role at Kura, she served for seven years as Senior Director, Financial Reporting at Halozyme Therapeutics, a publicly traded biotech company specializing in cancer therapy development. From 2007-2008, Ms. Tran was Controller at Adventrx Pharmaceuticals, and from 2005-2008, was Director, Financial Reporting at Avanir Pharmaceuticals. Before her time in the science industry, she served as Corporate Controller at Island Pacific for seven years. She is a certified public accountant, and she received her Bachelors of Accounting from San Diego State University.